Literature DB >> 19200234

ALK (Anaplastic Lymphoma Kinase) expression in DRG neurons and its involvement in neuron-Schwann cells interaction.

Joffrey Degoutin1, Nicole Brunet-de Carvalho, Carmen Cifuentes-Diaz, Marc Vigny.   

Abstract

Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) transiently expressed in specific regions of the central and peripheral nervous systems. In this study, we focused on the rat developing dorsal root ganglion (DRG). This ganglion is composed of heterogeneous sensory neurons characterized by the expression of RTK for neurotrophic factors, such as the nerve growth factor receptor TrkA or the glial-derived neurotrophic factor family receptor Ret, which are specifically detected in nociceptive neurons. In DRG, ALK expression reached a maximum around birth. We showed that ALK is specifically present in a subtype of neurons during DRG development, and that the majority of these neurons co-expressed TrkA and Ret. Interestingly, we identified only one form (220 kDa) of ALK in DRG neurons both in vivo and in vitro. On the opposite, in transfected cells as well as in brain extracts, ALK was identified as two forms (220 and 140 kDa). The DRG is composed of neurons and glial cells, principally satellite Schwann cells. Thus, we hypothesized that the presence of satellite Schwann cells was involved in the absence of truncated ALK. Using two different cell types, HEK293 cells stably expressing ALK, and MSC80 cells, a previously described Schwann cell line, we showed that a factor secreted by the Schwann cells is likely involved in the absence of ALK cleavage. All these data hence open new perspectives concerning the role of ALK in the specification of nociceptive DRG neurons and in the neurons-Schwann cells interaction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200234     DOI: 10.1111/j.1460-9568.2008.06593.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  24 in total

Review 1.  Emerging importance of ALK in neuroblastoma.

Authors:  Anna M Azarova; Gargi Gautam; Rani E George
Journal:  Semin Cancer Biol       Date:  2011-09-16       Impact factor: 15.707

2.  Using In Vitro Electrophysiology to Screen Medications: Accumbal Plasticity as an Engram of Alcohol Dependence.

Authors:  R Renteria; Z M Jeanes; R A Mangieri; E Y Maier; D M Kircher; T R Buske; R A Morrisett
Journal:  Int Rev Neurobiol       Date:  2016-03-24       Impact factor: 3.230

3.  Glial-derived growth factor and pleiotrophin synergistically promote axonal regeneration in critical nerve injuries.

Authors:  Nesreen Zoghoul Alsmadi; Geetanjali S Bendale; Aswini Kanneganti; Tarik Shihabeddin; An H Nguyen; Elijah Hor; Swarup Dash; Benjamin Johnston; Rafael Granja-Vazquez; Mario I Romero-Ortega
Journal:  Acta Biomater       Date:  2018-07-29       Impact factor: 8.947

Review 4.  The connections between neural crest development and neuroblastoma.

Authors:  Manrong Jiang; Jennifer Stanke; Jill M Lahti
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

5.  Cooperative Cross-Talk between Neuroblastoma Subtypes Confers Resistance to Anaplastic Lymphoma Kinase Inhibition.

Authors:  Xiaocai Yan; Colin R Kennedy; Sarah B Tilkens; Olena Wiedemeier; Hong Guan; Jong-In Park; Andrew M Chan
Journal:  Genes Cancer       Date:  2011-05

Review 6.  Neuroblastoma: developmental biology, cancer genomics and immunotherapy.

Authors:  Nai-Kong V Cheung; Michael A Dyer
Journal:  Nat Rev Cancer       Date:  2013-06       Impact factor: 60.716

Review 7.  Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology.

Authors:  Bengt Hallberg; Ruth H Palmer
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

8.  Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions.

Authors:  Andrey V Reshetnyak; Phillip B Murray; Xiarong Shi; Elizabeth S Mo; Jyotidarsini Mohanty; Francisco Tome; Hanwen Bai; Murat Gunel; Irit Lax; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

9.  Jelly Belly trans-synaptic signaling to anaplastic lymphoma kinase regulates neurotransmission strength and synapse architecture.

Authors:  Jeffrey Rohrbough; Karla S Kent; Kendal Broadie; Joseph B Weiss
Journal:  Dev Neurobiol       Date:  2012-11-01       Impact factor: 3.964

Review 10.  Anaplastic lymphoma kinase: signalling in development and disease.

Authors:  Ruth H Palmer; Emma Vernersson; Caroline Grabbe; Bengt Hallberg
Journal:  Biochem J       Date:  2009-05-27       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.